BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15753293)

  • 1. Engineering of vault nanocapsules with enzymatic and fluorescent properties.
    Kickhoefer VA; Garcia Y; Mikyas Y; Johansson E; Zhou JC; Raval-Fernandes S; Minoofar P; Zink JI; Dunn B; Stewart PL; Rome LH
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4348-52. PubMed ID: 15753293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the vault particle as a platform technology.
    Rome LH; Kickhoefer VA
    ACS Nano; 2013 Feb; 7(2):889-902. PubMed ID: 23267674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.
    Mikyas Y; Makabi M; Raval-Fernandes S; Harrington L; Kickhoefer VA; Rome LH; Stewart PL
    J Mol Biol; 2004 Nov; 344(1):91-105. PubMed ID: 15504404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vault Nanoparticles: Chemical Modifications for Imaging and Enhanced Delivery.
    Benner NL; Zang X; Buehler DC; Kickhoefer VA; Rome ME; Rome LH; Wender PA
    ACS Nano; 2017 Jan; 11(1):872-881. PubMed ID: 28029784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of a protein "shuttle" to load vault nanocapsules with gold probes and proteins.
    Goldsmith LE; Pupols M; Kickhoefer VA; Rome LH; Monbouquette HG
    ACS Nano; 2009 Oct; 3(10):3175-83. PubMed ID: 19775119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Movement of vault particles visualized by GFP-tagged major vault protein.
    Slesina M; Inman EM; Moore AE; Goldhaber JI; Rome LH; Volknandt W
    Cell Tissue Res; 2006 Jun; 324(3):403-10. PubMed ID: 16505994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm.
    Han M; Kickhoefer VA; Nemerow GR; Rome LH
    ACS Nano; 2011 Aug; 5(8):6128-37. PubMed ID: 21740042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vault nanoparticles engineered with the protein transduction domain, TAT48, enhances cellular uptake.
    Yang J; Srinivasan A; Sun Y; Mrazek J; Shu Z; Kickhoefer VA; Rome LH
    Integr Biol (Camb); 2013 Jan; 5(1):151-8. PubMed ID: 22785558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaults are dynamically unconstrained cytoplasmic nanoparticles capable of half vault exchange.
    Yang J; Kickhoefer VA; Ng BC; Gopal A; Bentolila LA; John S; Tolbert SH; Rome LH
    ACS Nano; 2010 Dec; 4(12):7229-40. PubMed ID: 21121616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulation of Exogenous Proteins in Vault Nanoparticles.
    Wang M; Abad D; Kickhoefer VA; Rome LH; Mahendra S
    Methods Mol Biol; 2018; 1798():25-37. PubMed ID: 29868949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immobilization of recombinant vault nanoparticles on solid substrates.
    Xia Y; Ramgopal Y; Li H; Shang L; Srinivas P; Kickhoefer VA; Rome LH; Preiser PR; Boey F; Zhang H; Venkatraman SS
    ACS Nano; 2010 Mar; 4(3):1417-24. PubMed ID: 20146454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaults engineered for hydrophobic drug delivery.
    Buehler DC; Toso DB; Kickhoefer VA; Zhou ZH; Rome LH
    Small; 2011 May; 7(10):1432-9. PubMed ID: 21506266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and assembly of human vault particles in yeast.
    Wang M; Kickhoefer VA; Rome LH; Foellmer OK; Mahendra S
    Biotechnol Bioeng; 2018 Dec; 115(12):2941-2950. PubMed ID: 30171681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vault complex.
    van Zon A; Mossink MH; Scheper RJ; Sonneveld P; Wiemer EA
    Cell Mol Life Sci; 2003 Sep; 60(9):1828-37. PubMed ID: 14523546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sea urchin vault structure, composition, and differential localization during development.
    Stewart PL; Makabi M; Lang J; Dickey-Sims C; Robertson AJ; Coffman JA; Suprenant KA
    BMC Dev Biol; 2005 Feb; 5():3. PubMed ID: 15710043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural stability of vault particles.
    Esfandiary R; Kickhoefer VA; Rome LH; Joshi SB; Middaugh CR
    J Pharm Sci; 2009 Apr; 98(4):1376-86. PubMed ID: 18683860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vault nanocapsule dissociation into halves triggered at low pH.
    Goldsmith LE; Yu M; Rome LH; Monbouquette HG
    Biochemistry; 2007 Mar; 46(10):2865-75. PubMed ID: 17302392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
    van Zon A; Mossink MH; Schoester M; Scheper RJ; Sonneveld P; Wiemer EA
    Cancer Res; 2004 Jul; 64(14):4887-92. PubMed ID: 15256459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vault Nanoparticles Packaged with Enzymes as an Efficient Pollutant Biodegradation Technology.
    Wang M; Abad D; Kickhoefer VA; Rome LH; Mahendra S
    ACS Nano; 2015 Nov; 9(11):10931-40. PubMed ID: 26493711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The formation of vault-tubes: a dynamic interaction between vaults and vault PARP.
    van Zon A; Mossink MH; Schoester M; Houtsmuller AB; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
    J Cell Sci; 2003 Nov; 116(Pt 21):4391-400. PubMed ID: 13130096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.